墨西哥儿科神经瘤实践的资源:一个横截面评估
Daniela Arce-Cabrera1, Gabriela Escamilla-Asiain2, Melisa F Nájera-Castillo3
1Pediatric Oncology Department, Sinaloa Pediatric Hospital, Culiacan, Sinaloa, Mexico.
Frontiers in oncology
|July 8, 2024
概括
这项研究评估了墨西哥儿科神经瘤学资源,揭示了专门人员,诊断能力和获得中枢神经系统 (CNS) 瘤先进治疗方法的重大缺口. 调查结果突出了差异和改善护理能力的需要.
科学领域:
- 在瘤学瘤学.
- 儿科 儿科 儿科
- 医疗保健服务研究 医疗服务研究
背景情况:
- 评估现有的儿科神经瘤学 (PNO) 资源对于识别缺口和改善中枢神经系统 (CNS) 瘤儿童的护理能力至关重要.
- 这项研究旨在评估墨西哥可用的PNO资源和服务.
研究的目的:
- 在墨西哥进行治疗儿科中枢神经系统瘤资源的首次全国性评估.
- 识别资源能力和诊断/治疗能力的差异.
主要方法:
- 对墨西哥儿科瘤和血液学协会 (AMOHP) 的成员进行了一项由35个问题组成的横截面在线调查.
- 该调查评估了墨西哥各个卫生系统的患者数量,基础设施,人力资源和诊断/治疗时间间隔.
主要成果:
- 33个机构做出了回应,其中64%的机构每年看到的儿童中枢神经系统瘤病例不到10例.
- 在儿科瘤学家 (73%的机构有1-3),神经外科医生 (18%缺乏任何,57%有儿科专家) 和有针对性的治疗 (18%有) 中发现了显著的短缺.
- 许多中心将放射治疗转移到外部 (55%),55%的受访者估计生存率低于60%,非瘤因素的死亡率高.
结论:
- 这是墨西哥PNO资源的首次全国性评估,揭示了显著的差异和缺乏专业诊断以及时启动治疗.
- 这些发现强调了需要优先考虑的协作干预措施,以提高墨西哥儿童中枢神经系统瘤的护理能力.
相关概念视频
01:21Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K